In Patient 3, three genomic loci—9p21 (CDKN2A and MTAP), 11q13 (OVOL1), and 11p15 (HRAS)—were homozygously deleted in the primary site tumor population (3PST) but not in the metastatic tumor population (3MT). The gene discussed is CDKN2A; the disease is neoplasm.